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Estrogens can induce rapid, short-lived physiological and behavioral responses, in
addition to their slow, but long-term, effects at the transcriptional level. To be
functionally relevant, these effects should be associated with rapid modulations of
estrogens concentrations. 17β-estradiol is synthesized by the enzyme aromatase,
using testosterone as a substrate, but can also be degraded into catechol-estrogens
via hydroxylation by the same enzyme, leading to an increase or decrease in
estrogens concentration, respectively. The first evidence that aromatase activity (AA)
can be rapidly modulated came from experiments performed in Japanese quail
hypothalamus homogenates. This rapid modulation is triggered by calcium-dependent
phosphorylations and was confirmed in other tissues and species. The mechanisms
controlling the phosphorylation status, the targeted amino acid residues and the
reversibility seem to vary depending of the tissues and is discussed in this review. We
currently do not know whether the phosphorylation of the same amino acid affects both
aromatase and/or hydroxylase activities or whether these residues are different. These
processes provide a new general mechanism by which local estrogen concentration can
be rapidly altered in the brain and other tissues.
Keywords: aromatase, hypothalamus, 17β-estradiol, catechol-estrogens, phosphorylation, neurosteroidogenesis
Introduction
The local conversion of androgens into estrogens in specific areas of the central nervous sys-
tem is an essential step in the activation of numerous testosterone-dependent physiological and
behavioral processes, including sexual differentiation of the brain, negative feedback on the
secretion of gonadotrophin releasing hormone and the activation of male sexual and aggres-
sive behaviors (Beyer et al., 1976; MacLusky and Naftolin, 1981; Bagatell et al., 1994; Fisher
et al., 1998; Honda et al., 1998; Toda et al., 2001; Rochira et al., 2006; Trainor et al., 2006).
This transformation is catalyzed by the enzyme aromatase, also known as CYP 19 or estro-
gen synthase. In most vertebrates, central aromatase expression is restricted to specific neuronal
populations mainly located in the hypothalamic/preoptic areas including the medial preoptic
nucleus and in the limbic system (Roselli et al., 1985; Foidart et al., 1995a,b; Wagner and Mor-
rell, 1997; Trainor et al., 2007; Metzdorf et al., 1999; Roselli and Resko, 2001). It should be
noted that songbirds have an additional population of aromatase expressing neurons in the cau-
domedial nidopallium, in the telencephalon (NCM; Shen et al., 1995; Saldanha et al., 2000).
Aromatase is also abundantly expressed in the whole brain of teleost fishes but only in glial cells
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(Forlano et al., 2001, 2006; Diotel et al., 2010). The presence
of aromatase in defined brain areas allows for local increase in
estrogens (17β-estradiol or E2) without affecting the periphery
or surrounding brain regions. The estrogens resulting from local
aromatization bind to estrogen receptors alpha or beta, trigger a
conformational change and dimerization of the receptor, and lead
the receptor to translocate to the nucleus. The receptor dimer
then binds to a specific response element on the DNA, usually but
not only, upstream of the target gene, recruits a set of transcrip-
tional coregulators and enhances or reduces gene transcription.
This modulation of transcription affects the physiology of the cell
and ultimately the functioning of the organ and the entire organ-
ism. The actions of estrogens at this genomic level develop rela-
tively slowly (several minutes but usually several hours to several
days) and have long lasting effects on the physiology, from sev-
eral days to a life time. However, numerous laboratories have now
described estrogen-dependent physiological changes that occur
much more rapidly and independently of mRNA transcription
and protein synthesis. For example, an acute estrogenic treatment
in vitro triggers the activation of numerous intracellular signaling
pathways including phosphorylation of the mitogen-activated
protein kinase (MAPK) and cAMP response element binding
protein (CREB) and changes in intracellular calcium concentra-
tions (Mermelstein et al., 1996; Moss et al., 1997; Kenealy et al.,
2011; Roepke et al., 2005). In the brain, these modifications lead
to modulations of neuronal activity (Joels, 1997; Moss et al., 1997;
Rønnekleiv and Kelly, 2002; Abraham et al., 2003, 2004; Boul-
ware et al., 2005) and can in some instance rapidly affect behavior
in numerous species (Hayden-Hixson and Ferris, 1991; Remage-
Healey and Bass, 2004; Dewing et al., 2007; Micevych and Mer-
melstein, 2008; Lord et al., 2009; Seredynski et al., 2013; see Cornil
et al., 2012a for review). These observations led to the hypothe-
sis that estrogens are not only slow acting signaling molecules, or
hormones, but can also function more rapidly like classical neu-
rotransmitters, such as glutamate or dopamine (Balthazart and
Ball, 2006; Saldanha et al., 2011).
While these rapid, non-genomic, effects of estrogens are cur-
rently the focus of intense research, they raise the question of
how rapid increases of estrogens can occur. Indeed, estrogens,
like other steroids, cannot be stored in synaptic vesicles before
rapid release due to their lipophilic nature. We therefore sug-
gested that the fast effects of estrogens require a rapid change of
local steroid concentration via rapid changes in their synthesis
rate by androgen conversion (Balthazart and Ball, 2006; Cornil
et al., 2006), therefore implicating changes in aromatase activity
(AA). Changes in AA often reflect changes in aromatase protein
concentration resulting from relatively slow transcriptional con-
trol. For example, aromatase expression in the hypothalamus in
most vertebrates is controlled by sex steroids: weak aromatase
expression is detected in castrated males, while testosterone
replacement markedly increases aromatase transcript, protein
and activity (Roselli and Resko, 1984, 1989; Schumacher and
Balthazart, 1986; Fusani et al., 2001). These changes in AA gen-
erally occur after several hours or days of treatment. However,
the rapid effects of E2 introduced above require mechanisms
affecting the synthesis of the steroid more rapidly, suggesting
posttranslational change(s) of the protein activity.
Rapid Modulation of Aromatase Activity
The first evidence that AA is rapidly modulated was obtained in
preoptic area/hypothalamus explants from Japanese quail. A rise
in extracellular K+ concentration or an increase of intracellular
calcium concentration rapidly (5min) and transiently reduced
AA (Balthazart et al., 2001b). These results suggested that the
K+-induced transient depolarization resulted in an increase of
Ca++ from intracellular stores and led to a rapid reduction of AA.
In agreement with this hypothesis, the inhibition of enzymatic
activity was significantly hindered when the K+-induced depo-
larization was performed in a Ca++-free medium (Balthazart
et al., 2001b). In a different model, the zebra finch telencephalon,
Remage–Healey and colleagues showed that a K+-induced depo-
larization and the increase of intracellular calcium concentra-
tions were also able to significantly reduce AA, as suggested by
the rapid reduction of E2 concentrations measured by ELISA
on NCMmicrodialysates (Remage-Healey et al., 2011). However,
the increase in calcium concentrations in this model resulted
from the activation of voltage-gated calcium channels, and not
from a release from intracellular stores. Indeed, the use of ω–
conotoxin, a specific inhibitor of N-type Ca++ channel, blocked
the K+-induced decrease in E2 concentration (Remage-Healey
et al., 2011).
Glutamate
Our group investigated physiologically relevant signal-
ing molecules that could affect the local concentrations
of calcium in the brain and investigated whether the
activation of glutamate receptors could lead to a rapid
modulation of AA in male quail preoptic/hypothalamic
explants. We found that the glutamate agonists AMPA
[2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl) propanoic acid],
kainate and, to a some extent, NMDA (N-methyl-D-aspartate)
rapidly and reversibly down-regulated AA from quail hypotha-
lamic explants. Addition of the glutamate receptor antagonist
NBQX blocked the effect of kainate on AA, confirming the
specificity of the treatments (Balthazart et al., 2006). Interest-
ingly, intracellular recording combined with biocytin labeling
of aromatase-positive neurons confirm that these neurons are
sensitive to glutamate, a finding consistent with the idea that
glutamatergic inputs on aromatase cells acutely regulate AA
(Cornil et al., 2000, 2004). In parallel, in vivo retrodialysis of
glutamate in the zebra finch telencephalon induced a significant
reduction of local E2 concentration, while NMDA had no
apparent effect (Remage-Healey et al., 2008).
Dopamine
It should be noted that dopaminergic signaling could also be
involved in the rapid modulation of AA. Double immunocyto-
chemistry highlighted a close interaction between dopaminergic
fibers (tyrosine hydroxylase-positive structures) and aromatase-
positive cells in the hypothalamus of Japanese quail (Balthaz-
art et al., 1998). More importantly, several dopaminergic drugs
rapidly inhibited AA in homogenates and in vitro explants
obtained from the preoptic area hypothalamus of male Japanese
quail (Baillien and Balthazart, 1997; Balthazart et al., 2002).This
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inhibition was fully reversible in explant when the compounds
were removed from the incubation medium (Absil et al., 2001).
Surprisingly, agonists as well as antagonists of dopamine, specific
for the D1 or D2 receptors, depressed AA in explants incubated
in vitro, raising questions about the exact mechanism underly-
ing the potential implication of D1 or D2 receptors. In addition,
the observation that the dopamine reuptake inhibitor nomifen-
sine had no effect in homogenates but strongly inhibits AA in
explants suggests that the accumulation of dopamine within the
synaptic cleft is the cause of AA inhibition.
GABA
Another neurotransmitter, the inhibitory amino acid GABA, did
not affect the enzymatic activity in quail preoptic hypothalamus
explants nor in vivo in zebra finch telencephalon (Balthazart et al.,
2001b; Remage-Healey et al., 2008). It is therefore obvious that
the direct links between the activation of the membrane receptor,
calcium release and the exact intracellular pathway(s) involved in
the rapid modulation of AA require further investigation.
Post-translational Modifications of
Aromatase Activity by Phosphorylation
Post-translational modifications are a common mechanism
involved in the control of protein activity and is a widely used
regulatorymechanism in the brain to control for example NMDA
receptor activity in hippocampal neurons (Chen and Roche,
2007) and tyrosine hydroxylase activity, the rate-limiting enzyme
in catecholamine synthesis (Albert et al., 1984; Daubner et al.,
1992). These phosphorylations are catalyzed by specific kinases
that critically depend on the intracellular concentration of Ca++
and Mg++. Interestingly, previous studies have implicated diva-
lent cations in the control of AA (Ca++: Onagbesan and Ped-
die, 1989; Mg++: Steimer and Hutchison, 1991). We therefore
wondered whether Ca++ and Mg++, in addition of adenosine
triphosphate ATP as a phosphate donor, during phosphoryla-
tion process could also potentially affect AA. We showed that
exposure to ATP (2–8mM), Ca++ (0.5–2mM), and Mg++ (2–
10mM) rapidly and significantly inhibited AA in male Japanese
quail preoptic area/hypothalamus homogenate (Balthazart et al.,
2001b), strongly suggesting that phosphorylations rapidly inhibit
this enzymatic activity. To test whether ATP/Mg/Ca conditions
induce kinase-dependent protein phosphorylations or whether
these conditions result in a non-specific inactivation of AA, we
tested effects of the second messengers cAMP and cGMP, respec-
tively activators of protein kinase A, PKA and protein kinase G,
PKG. These kinase activators did notmodify AA in the absence or
presence of ATP/Mg/Ca (Balthazart et al., 2003). We also tested
the effects of numerous kinase inhibitors on the AA of preop-
tic area/hypothalamic homogenates in the presence or absence of
ATP/Mg/Ca (Balthazart et al., 2003). Several of these inhibitors
significantly blocked the inhibition of AA induced by the addi-
tion of ATP/Mg/Ca while others had no effect. The general ser-
ine/threonine (Ser/Thr) kinase inhibitor Staurosporine (STAU),
and the general tyrosine (Tyr) kinase inhibitor genistein (GEN)
significantly blocked the inhibition produced by ATP/Mg/Ca
while they had no effect on basal AA. Similar effects (block-
ade of inhibition) were also observed in presence of the PKC
inhibitor bisindolylmaleimide, the myosin light chain kinase
inhibitor ML7, the inhibitor of PKA and PKC H7, the spe-
cific inhibitor of PKA/PKG H9, the PKA inhibitor H89 and the
calmodulin antagonist trifluoperazin. Altogether, these data indi-
cate that rapid modulation of AA results from the phosphoryla-
tion of both Tyr and Ser/Thr residues (Balthazart et al., 2001a,
2003). It should be noted that the potential quantitative role of
each kinase family in the rapidmodulation of AA in homogenates
seems to vary according to the sex: While the addition of pro-
tein kinase inhibitors blocked the ATP/Mg/Ca-dependent inhi-
bition AA in both sexes, the magnitude of these effects were
sexually differentiated and usually more pronounced in females
compared to males (Konkle and Balthazart, 2011). Moreover,
phosphorylating conditions affected AA differentially in 2 sub-
cellular compartments isolated via differential ultracentrifuga-
tion from zebra finch telencephalon. The reduction of AA by
phosphorylating conditions was significantly more pronounced
in the fraction containing synaptosomes (P2), as compared to
microsomes (endoplasmic reticulum, P3 fractions, Cornil et al.,
2012b).
We further investigated whether the rapid inhibition of AA
by ATP/Mg/Ca-dependent phosphorylation processes is spe-
cific to the neuronal environment or can be observed in other
aromatase-rich tissues. Effects of phosphorylating conditions
were quantified in ovary and ovarian follicles homogenates from
Japanese quail and demonstrated a drastic decrease in enzymatic
activity within 15min (Charlier et al., 2011). We also transiently
and stably expressed human aromatase in HEK293 cells. Simi-
larly to what was observed in the preoptic area/hypothalamus of
Japanese quail and telencephalon of zebra finch, a K+-induced
depolarization triggered a pronounced but transient inhibition
of AA expressed by transfected HEK293 cells. In addition, we
also showed that phosphorylating conditions did not affect the
enzyme affinity for the substrate but only changed the maxi-
mum velocity of reaction. Interestingly, the rapid enzymatic inhi-
bition induced by depolarization also involved the activity of
protein kinases as the addition of staurosporine (Ser/Thr kinase
inhibitor) or Genistein (Tyr kinase inhibitor) blocked the effect of
K+-induced depolarizations on AA (Charlier et al., 2011). These
observations are contrasting to what is observed in the breast
cancer cell line MCF-7. Indeed, Catalano et al. (2009) showed
that E2 rapidly modulates c-Src kinase action on aromatase tyro-
sine residues to enhance AA. It should however be noted that
these effects were observed after 5 h of incubation and might be
underlying different physiological processes.
In both cases however, the rapid change in AA is reversible,
suggesting (1) that phosphorylation does not involve protein
degradation when AA is reduced (Charlier et al., 2011) and
(2) phosphatase is required to restore the un-phosphorylated
stage. Interestingly, the general inhibitor of protein phosphatases
(PPase), vanadate, did not significantly increase AA but reduced
it in male quail preoptic area/hypothalamic homogenates. In
addition, alkaline PPase inhibited AA in a dose-dependent man-
ner in the presence, as well as in the absence, of ATP/Mg/Ca
(Balthazart et al., 2005). In contrast, preincubation with acid
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PPase completely blocked the inhibitory effects of ATP/Mg/Ca on
AA although the addition of the PPase was unable to restore AA
after the enzymatic activity had been inhibited by the phosphory-
lating conditions. Moreover, high concentrations of acid PPase
also moderately inhibited AA in the absence of ATP/Mg/Ca
(Balthazart et al., 2005). It should be noted that recent work
on human placental choriocarcinoma cell line JEG-3 demon-
strated that microsomal aromatase was rapidly inactivated with
calcium, magnesium, and ATP, similarly to what is observed in
quail preoptic area/hypothalamus homogenate and transfected
cell lines, but the protein was then subsequently degraded in
these conditions (Hayashi and Harada, 2014). More specifically,
aromatase was protected from protein degradation by treatment
with alkaline phosphatase, whereas degradation was enhanced by
treatment with the phosphatase (calcineurin) inhibitors FK506
and cyclosporin A. Furthermore, aromatase was protected from
degradation by treatment with kinase inhibitors, especially the
calcium/calmodulin kinase inhibitors KN62 and KN93 (Hayashi
and Harada, 2014).
It is therefore possible aromatase can first be rapidly inacti-
vated by phosphorylation, then follow 2 different paths: either
(1) its activity is restituted by dephosphorylation following
interaction with phosphatase, or (2) the absence of dephospho-
rylation leads to subsequent degradation, i.e., a permanent inac-
tivity of the enzyme. However, the specific enzymes involved
in the phosphorylation-dephosphorylation mechanisms associ-
ated to the rapid and reversible control of AA are not fully
defined and are currently under further investigation. It should
also be noted that tyrosine phosphatase PTP1B was shown to
reduce AA in MCF-7 and ZR75 breast cancer cells (Barone et al.,
2012). Altogether, this suggests that some level of phosphoryla-
tion is required for a fully functional activity but future work
should define in more detail the intricate role of phosphatases
and kinases in the control of AA in different cell types.
Evidence for the Direct Phosphorylation of
the Aromatase Protein
Our next question was to define whether phosphorylations con-
trolling enzymatic activity directly affect the aromatase itself or
modulate the activity of a cofactor that could secondarily regu-
late AA.We purified by immunoprecipitation the aromatase pro-
tein from quail preoptic area/hypothalamic homogenates and the
presence of phosphorylated residues on the purified protein was
investigated by Western blotting using anti-phosphoserine, anti-
phosphothreonine or anti-phosphotyrosine antibodies. Confirm-
ing the pharmacological finding described above, phosphorylated
Ser, Thr, or Tyr were identified by the specific antibodies at the
level of the electrophoresis band corresponding to aromatase
and the intensity of the phosphorylation signal was denser when
homogenates were pre-incubated with ATP/Mg/Ca as compared
to homogenates incubated in control conditions (Balthazart et al.,
2003).
Similar experiments were performed on engineered human
aromatase containing a c-myc tag that allows its specific
immunoprecipitation. HEK293 cells transfected with this
construct were incubated with [γ-32P]-ATP in phosphorylating
or non-phosphorylating (control) conditions. The radioactive
aromatase c-myc in phosphorylating conditions was clearly
observed at the expected molecular weight while only a low-
intensity band was present in control conditions (Charlier
et al., 2011). In additional experiments, the immunoprecipitated
aromatase obtained after a 5min-incubation of the cell lysate in
phosphorylating conditions was clearly visible at the expected
size on immunoblot when visualized with anti-phosphoserine
antibody, while that band was not present in different control
conditions (Charlier et al., 2011). This set of experiments clearly
supports the hypothesis that the aromatase protein itself is
rapidly phosphorylated in the presence of ATP/Mg/Ca, leading
to a reduction of its enzymatic activity. Similarly, immuno-
precipitation of His6-tagged aromatase in MCF-7 cells and
investigation of phosphorylated amino acid by immunoblotting
revealed that aromatase tyrosine residue is directly targeted by
the kinase c-Src (Catalano et al., 2009, 2014).
Identification of Aromatase Residues
Involved in the Rapid Control of Activity
This set of pharmacological experiments on quail hypothalamus
explants and homogenates and the manipulations performed
with immunoprecipitated human aromatase indicated that the
inhibition of AA by phosphorylation is likely to be catalyzed
by the activity of two Ser/Thr kinases, protein kinase A (PKA)
and C (PKC), although the implication of tyrosine kinase and
other Ser/Thr kinases cannot be completely ruled out (Balthaz-
art et al., 2003; Charlier et al., 2011). The quail and human
aromatase protein sequence were analyzed using bioinformatic
tools to identify the potential phosphorylation sites, highly con-
served amongst several avian and mammalian species. Fifteen
and nineteen putative phosphorylation sites were identified for
quail and human sequences respectively using the open access
NETPHOS 2.0 program. These sites included 10 of the 27 serines,
5 of the 24 threonines, and 4 of the 17 tyrosines residues on the
human sequence and we paralleled these findings with the results
obtained using NETPHOSK, highlighting consensus sequences
corresponding to PKC and PKA, protein kinases shown to affect
quail and human AA during the pharmacological experiments
(Balthazart et al., 2003; Charlier et al., 2011). The output pointed
to 6 different residues, five serines (S118, S167, S247, S267, S497),
and one threonine (T143) on the human sequence. It should be
pointed out that other kinases might also be involved, as consen-
sus binding sequence were observed on both quail and human
aromatase. These were however not investigated. From this anal-
ysis, we decided to focus our attention on 6 different residues:
S247, S267, and S497 that had high scores in both the predic-
tive phosphorylation sites and PKA or PKC recognition consen-
sus sequence; T462 and T493 that correspond to positions S455
and S486 in quail aromatase, two 2 residues that were predicted
to be involved in the phosphorylation of aromatase (Balthazart
et al., 2003). In addition, in vitro studies of the mouse aromatase
performed by 2 different groups suggested that 2 other amino
acid residues, namely serine S118 (Miller et al., 2008) or tyrosine
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Y361 (Catalano et al., 2009) can be phosphorylated. Indeed, the
phosphorylation of Y361 triggered by the tyrosine-kinase c-Src
seems involved in the E2-dependent upregulation of AA in breast
cancer cell lines (Catalano et al., 2009) while phosphorylation
of S188 by AGC-like kinases, including PKC and PKA, seems
important for the stabilization of the protein, and therefore for
the expression of AA (Miller et al., 2008). It should be noted that
the effects of the phosphorylation status of these 2 residues on
the rapid change of AA was not investigated and we explored the
potential implication of S188 phosphorylation (not Y361) in the
rapid control of AA.
Altogether, we investigated the consequence of mutat-
ing 6 S/T residues into alanine (A) using the human aro-
matase as template. All mutants expressed normal baseline
AA and pre-incubation with ATP/Ca/Mg for 15min markedly
reduced this enzymatic activity in the 6 different mutants alone
(S118A, S247A, S267A, T462A, T493A, S497A) or in com-
bination (S267A-S247A, T493A-T462A-S267A, T493A-T462A-
S267A-S247A, S497A-T493A-T462A-S267A-S247A) roughly to
the same extent as in wild type enzyme, clearly showing that these
single or combined mutations did not block the rapid inhibi-
tion of aromatase by phosphorylating conditions. The absence of
effect, against all expectations, was thoroughly discussed in the
original article (Charlier et al., 2011). In summary, it is likely
that a combination of several phosphorylated residues that was
not tested here is required to control AA. The control by mul-
tiple kinases reinforces the idea that several amino acids must
concomitantly be phosphorylated to modify AA. It is possible
that other consensus sites for phosphorylations and for other
types of kinases that were also predicted on the quail and human
aromatase sequences might be involved. Alternatively, it is pos-
sible that the control of AA by phosphorylations depends on the
modulation of certain factors interacting with aromatase, in addi-
tion to the enzyme itself. Aromatase requires the presence of an
active NADPH-cytochrome P450 reductase for electron transfer
(Thompson and Siiteri, 1974;Miller, 2005; Hong et al., 2009). The
phosphorylation of the reductase could be a control mechanism
affecting the electron transfer and this idea should be further
investigated.
Behavior and Rapid Modulation of
Aromatase Activity
It is important to note that the change in enzymatic activity
resulting from the phosphorylation of aromatase is physiolog-
ically and behaviorally relevant. Indeed, rapid changes in AA
were demonstrated to occur in vivo in response to social inter-
actions in a few species investigated to date, including birds
and fish. For example, expression of appetitive or consummatory
sexual behavior rapidly reduces AA in specific brain regions in
the preoptic-hypothalamic area of quail after 5–30min of sex-
ual interaction with a receptive female (Cornil et al., 2005a; de
Bournonville et al., 2013) while exposure to acute restraint stress,
or stress-related hormones such as AVT and corticosterone lead
to an increase in AA in bothmale and female quail (Dickens et al.,
2011, 2013). Male removal from a socially stable group of the
FIGURE 1 | Schematic diagram representing the mechanisms
involved in the rapid control of aromatase activity.
Phosphorylations (PO4) rapidly modulate aromatase activity, inhibiting the
transformation of testosterone (T) into 17β-estradiol (E2). It is likely that
these modifications are induced by calcium-voltage channels, by
glutamatergic receptors and/or by dopaminergic receptors. The increase
of intracellular calcium (Ca++), either from intracellular storage or from
the activation of voltage-gated channel is in most cases a prerequisite
for the inhibition of aromatase activity. Change in phosphorylation level
could also affect the hydroxylase activity of aromatase.
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sex-changing fish Lythrypnus dalli resulted in rapid increases in
aggression associated with a rapid reduction in brain AA in the
dominant female (Black et al., 2005, 2011). Conversely in zebra
finches, a brief exposure to song (30min) resulted in an increase
of AA in NCM within the telencephalon (Remage-Healey et al.,
2009). While behavior can affect AA, the reverse is also true
and recent studies showed that rapid changes in AA modulate
behavior and sensory processing. Indeed, an acute systemic or
central administration of aromatase inhibitors such as Vorozole
or Androstatrienedione significantly and rapidly reduced male
sexual behavior in quail and mice (Cornil et al., 2005b; Taziaux
et al., 2007; Seredynski et al., 2013), approach behavior toward
females in male goldfish (Lord et al., 2009), aggressive behavior in
Beach and California mice (Trainor et al., 2007, 2008) and vocal-
izations in midshipman fish (Remage-Healey and Bass, 2004).
Fadrozole, another aromatase inhibitor, rapidly suppressed the
preference for a bird’s own song in male zebra finches (Remage-
Healey et al., 2010) and reduced song-elicited neuronal firing rate
in zebra finches and prevented the expression of hearing-driven
gene expression in NCM, a brain regions involved in song dis-
crimination in songbirds (Tremere et al., 2009). Altogether, this
clearly confirms that the rapid modulation of AA, likely by phos-
phorylation, is of physiological importance. This also shows that
the rapid inhibition of AA rapidly influences the physiology and
behavior.
Catabolism of Estrogens
Therefore, there must exist some mechanisms that are able to
rapidly clear locally-produced estrogens to terminate their effects.
The half-life of E2 in the brain is not known, although calcula-
tions derived from pharmacokinetic data estimated that its half-
life in the blood is below 30min (Johnson and van Tienhoven,
1981; Tsang and Grunder, 1984). The liver is known to express
several enzymes involved in the clearance of circulating estro-
gens, notably CYP1A1, CYP1A2, CYP1B1, and CYP3A (Whirl-
Carrillo et al., 2012). These enzymes catalyze the conversion
of estrogen into inactive (or less active) water-soluble metabo-
lites by oxidative metabolism and allow for further sulfation by
sulfotransferases, glucuronidation by glucoronyltransferases, or
methylation by catecholmethyltransferases. The elimination of
plasma estrogens from the organism is ensured through excretion
following their conjugation. Although this type of degradation
of estrogens occurs mainly in the liver, some catabolic activ-
ity is also observed in the brain, albeit to a much lower extent.
We hypothesized that the rapid elimination of estrogens in the
brain involves the enzyme aromatase itself. Indeed, a few studies
suggest that, in addition to its estrogen synthase activity, aro-
matase also catalyzes estrogen hydroxylation. A previous study
in Japanese quail showed that 2-hydroxylase enzymatic activity
is present in all brain regions that are known to contain a high
level of AA, including the median preoptic nucleus and the ven-
tromedial nucleus of the hypothalamus (Balthazart et al., 1994),
suggesting that the same protein is involved in both the pro-
duction and the conversion of estrogens. However, no sex dif-
ference in 2-hydroxylase activity was identified here, while AA
is higher in males than in females in almost every brain region.
The first evidence that aromatase protein also had estrogen
hydroxylase activity came fromOsawa et al. (1993). They demon-
strated that purified aromatase obtained from placental micro-
somes demonstrates an estrogen-2-hydroxylase activity in certain
conditions. Both aromatase and estradiol 2-hydroxylase activities
were observed after purification of human placental microsomal
cytochrome P-450 by monoclonal antibody-based immunoaffin-
ity chromatography and gradient elution. Moreover, they con-
firmed the concomitant existence of estradiol hydroxylase activ-
ity with AA by expressing human aromatase in CHO cells. Not
only did the purified aromatase exhibit the hydroxylase activ-
ity but testosterone and androstenedione competitively inhib-
ited estradiol 2-hydroxylation, and conversely, estrone and estra-
diol competitively inhibited aromatization of both testosterone
and androstenedione. Similarly, equine aromatase expressed
in vitro has a clear hydroxylase activity (Almadhidi et al.,
1996). A specific antiserum raised against purified testicular
equine P450arom and known to inhibit AA was also found
to inhibit the estrogen hydroxylase activity of equine placental
microsomes. Furthermore, the estrogen hydroxylase activity was
inhibited in a dose-dependent manner by different aromatase
inhibitors, including fadrozole and 4-hydroxyandrostenedione
(Almadhidi et al., 1996). It remains to be determined whether
the phosphorylation of the same residue(s) leads to the rapid
reduction of both estrogen synthase and estrogen hydroxylase
activity.
Conclusions
Altogether, a few laboratories have accumulated strong evi-
dence showing that AA can be rapidly modulated via post-
translational modifications, most notably via phosphorylation
(see Figure 1 for general model). The rapid modulation of AA by
phosphorylating conditions is a widespread mechanism present
in different tissues affecting aromatase from various species,
including humans. The mechanisms leading to these modifi-
cations remain poorly understood, but it is increasingly clear
that the enzymatic changes must result in a local rapid modula-
tion of estrogens availability and consequently in a modification
of cellular estrogen-dependent events that are not mediated
by the genomic actions of these steroids. The phosphoryla-
tion/dephosphorylation processes provide a new widespread
mechanism by which estrogens concentration could be rapidly
altered in the brain and other tissues, albeit likely in different
directions. It would be interesting to test whether precise phos-
phorylation patterns affect one type of enzymatic activity while
leaving the other untouched or whether phosphorylation is a gen-
eral shut-down switch for all enzymatic activity displayed by the
aromatase protein.
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